08/27/2025
3:56 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2025
3:56 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2025
3:59 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2025
4:01 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2025
3:28 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2025
3:18 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2025
3:19 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2025
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2025
3:37 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2025
3:38 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2025
3:09 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for SUPN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Supernus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
08/22/2025
4:04 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2025
3:47 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2025
3:26 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2025
3:31 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2025
11:28 AM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
3:33 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2025
3:40 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
3:43 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
3:23 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2025
7:58 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
8:06 AM | Sage Therapeutics, Inc. (Subject)
Supernus Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
07/28/2025
7:40 AM | Sage Therapeutics, Inc. (Subject)
Supernus Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
06/17/2025
3:40 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
4:26 PM | Sage Therapeutics, Inc. (Subject)
Supernus Pharmaceuticals (Filed by)
| Form SC TO-C | |
06/16/2025
10:40 AM | Sage Therapeutics, Inc. (Subject)
Supernus Pharmaceuticals (Filed by)
| Form SC TO-C | |
06/16/2025
7:34 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
3:09 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
2:18 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/30/2025
3:17 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
4:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
7:27 AM | BlackRock, Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:27 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:17 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:34 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:40 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:56 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:13 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
7:16 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:18 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:20 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Capital Gains Tax Strategies for Seniors (Ad) Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure.
SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation. Click here to see the three strategies and get matched with a financial advisor today. |
02/24/2025
7:22 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:47 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:50 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:41 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:43 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:45 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:48 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:42 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:43 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:44 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:45 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:47 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:54 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:20 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:13 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:57 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:33 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4/A | |
02/05/2025
3:37 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:23 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
3:59 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:01 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:04 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:26 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
3:33 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:13 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:42 AM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:31 AM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:31 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:19 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:11 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
3:59 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
3:42 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:19 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:35 PM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
10:55 AM | DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:48 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:03 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:30 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access